Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

计划入组 100 人 · 首次发布于 2023 年 10 月 25 日

Cost-effectiveness of RFA vs. PEI for Early-stage HCC

计划入组 50 人 · 首次发布于 2024 年 6 月 10 日

Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma

计划入组 38 人 · 首次发布于 2013 年 6 月 14 日

PEi (Antabio)

PPY-PEI NC

HA-PEI/HA-PEG/MDR1 siRNA

Peijia Medical Technology (Suzhou) Co.,Ltd.

China

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori SRL

Romania

Per Humpert

Germany

Orphalan Makes History as First European Company to Enter China's Wilson Disease Market with "Ke Pei Ou"

VasoRx's Lipid Nanoparticle Drug Delivery System Targets TGFβ-Related Diseases

Interius BioTherapeutics' INT2104 In Vivo CAR-T Therapy Trial Expands to Europe